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Background and Aims. Endoscopic submucosal dissection (ESD) outcomes have traditionally been reported from high volume
centers in East Asia. Data from low volume centers in other parts of Asia remain sparse. Methods. A retrospective survey with
a structured questionnaire of 5 tertiary centers in 3 countries in South East Asia was conducted. Details of training and clinical
outcomes of ESD cases, with follow-up data from these centers, were analyzed. Results. Seven endoscopists from the 5 centers
performed a total of 35 cases of ESD in the upper gastrointestinal tract (UGIT) over a 6-year duration. Details of the lesions excised
were as follows: median size was 20mm, morphologically 20 (68.6%) were flat/depressed and 6 (17.1%) were submucosal, and
histologically 27 (77.1%) were neoplastic. The median duration of ESD procedures was 105 minutes, with an en-bloc resection rate
of 91.4%.There was 1 (2.9%) case of delayed bleeding, but no perforation nor mortality in any of the cases.The recurrence rate after
ESD was 5.7%. A prolonged ESD duration was influenced by a larger size of lesion (25mm, 𝑝 = 0.02) but not by factors related to
the training experience of endoscopists. Conclusions. ESD in the UGIT is feasible and safe in low volume centers in Asia.
1. Introduction
Endoscopic resection is the least invasive and cost-effective
way of treating superficial malignant lesions in the digestive
tract. Endoscopic submucosal dissection (ESD) has now
become the accepted technique of resection of early tumors
in the upper gastrointestinal (GI) tract, although it has long
been practiced among Japanese endoscopists who pioneered
this technique. ESD, however, is technically challenging
and is rarely practiced outside of Japan or Korea [1]. A
steep learning curve to master ESD, prolonged procedure
duration, increased procedure risks, lack of commensurate
reimbursement, and need for specialized tools have become
challenges in mastering ESD [2]. Endoscopic mucosal resec-
tion (EMR) is technically less demanding and seen by many
as an alternate method of endoscopic resection for early
GI neoplasia. However, EMR is unable to achieve en-bloc
resection for lesions >20mm in size and has been shown to
have a higher rate of tumor recurrence compared to ESD.
In Japan, several experts have suggested that competency
in ESD can only be achieved following supervised perfor-
mance of between 30 and 80 ESD cases [3]. Such a volume
of ESD cases may be easily achieved in a short space of
time in Japan and Korea, where a high incidence of early
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gastric cancer detection resulting from an active screening
programme is present [4, 5], but this is clearly not the case
elsewhere in Asia or in theWest [6].This does not necessarily
indicate then that ESD should not be practiced outside of
East Asia, as there is a growing indication for ESD beyond
early gastric malignancy, such as for submucosal GI tumors
[7–9]. As such, recent experts from the West have proposed
a variation to the Japanese recommendation for training in
ESD. In addition to being experienced in general therapeutic
GI endoscopy,Draganov et al. have suggested that proficiency
in conventional EMR, together with animal model training,
may be sufficient for endoscopists in the West to embark on
ESD in humans [10].
The incidence of gastric cancer in South East Asia is low
at 10.1 per 100,000 populations (age-standardised rates) [11].
Nevertheless, with its moderate/low prevalence of H. pylori
infection, early gastric cancer is not totally unrecognized
in the Southeast Asian region [12]. Recognizing the need
to develop ESD within their respective countries, several
endoscopic centers in South East Asia, namely, in Thailand,
Singapore, and Malaysia, had embarked on ESD for upper
GI tumors over the last 6 years. Specific individuals in each
center, usually with a background of EMR experience, under-
went training on animal models and performed ESD under
supervision by experts before embarking on the procedure
independently. This report aims to document the collective
feasibility and safety of ESD in the main centers performing
ESD in South East Asia.
2. Methods
ESD in the upper GI tract had been commenced in the fol-
lowing 5 centers in South East Asia over the past several years:
Chulalongkorn University Hospital and Rajavithi Hospital in
Bangkok; National University Hospital and Singapore Gen-
eral Hospital in Singapore; and University Malaya Medical
Center in Kuala Lumpur. Prospective data on experience
of ESD operators, procedure details, and clinical follow-up
information were obtained in all cases using a structured
clinical record form.
Data on ESD in the upper GI tract alone were collected in
this study, as mucosal or submucosal lesions in the esophagus
and stomach were the commonest indication for ESD in all
centers.
2.1. ESDTechnique. Prior to ESD, all gastric lesionswere care-
fully evaluated with chromoendoscopy and endoscopic ultra-
sound (EUS) where indicated. The endoscopic appearances
of mucosal lesions were classified based on the Paris Classi-
fication of superficial tumors [13]. Tissue biopsies were taken
in cases prior to ESD where indicated. ESD was performed
in a standard manner [14]. All patients had sedation, which
was administered by an anaesthetist. After chromoendoscopy
with 0.2% Indigo carmine dye to delineate the border of
the tumor, circumferential marking with a needle knife
(KD-1L-1, Olympus, Tokyo, Japan) or ERBE hybrid knife
(Erbe Elektromedizin GmbH, Tuebingen, Germany) was
made. Submucosal injection was performed using a standard
solution (Gelafundin or normal saline with Adrenaline and
Indigo carmine in a ratio of 20 : 1 : 1) [15]. After an adequate
submucosal lift of the periphery of the tumor was made, an
initial mucosal incision was performed (needle knife KD-1L-
1, Olympus, Tokyo, Japan, or ERBE hybrid knife). This was
followed by a circumferential incision and subsequent sub-
mucosal dissection using the IT2 knife, Dual knife (Olympus,
Tokyo, Japan) or ERBE hybrid knife (Erbe Elektromedizin
GmbH, Tuebingen, Germany), with repeated submucosal
injection where necessary. Following en-bloc resection of
the tumor, the mucosal defect was carefully inspected and
areas of bleeding or prominent vessels were cauterized using
hemostatic forceps (Olympus, Tokyo, Japan). After ESD, all
patients had a routine follow-up endoscopic examination at 1
month to check for ulcer healing and subsequently at 6 and
12 months. Further assessment was made depending on the
findings at repeat endoscopy.
2.2. Clinical Data Parameters. All resected specimens were
examined histologically based on the Vienna Classification
[16]. Involvement or clearance of the margins was recorded.
All patients’ vital signs were monitored after procedure.
Hemoglobin levels were checked on the day after the pro-
cedure routinely and were clinically indicated. Procedure
duration was described from the time the endoscope entered
the oral cavity until the time it was removed from the patients’
mouth. Complications were divided into intraprocedure and
postprocedure.These included immediate and delayed bleed-
ing, perforation, and complications associated with sedation.
Patients who had a reduction in hemoglobin by 2 g/dL or
requiring blood transfusion after procedure were labeled as
delayed bleeding. All patients were followed up for a median
period of 24 weeks. The endoscopic findings during follow-
up were recorded. “Local recurrence” was defined as the
presence of tumor after 2 negative gastroscopy follow-up
examinations.
2.3. Main Outcomes. The main outcomes of this study were
to examine the feasibility and safety of ESD in low volume
centers. Feasibility will be assessed with the following param-
eters: duration of ESD procedure, completeness of tissue
resection (by histological assessment), and recurrence rate
at follow-up endoscopy. The safety of ESD will be based on
the rates of immediate and delayed complications after ESD.
Comparisons with published data on ESD in both European
and Eastern (Korean and Japanese) series will be explored.
2.4. Statistical Analysis. All raw data obtained from each
center were recorded and analyzed using a standard software
package (SPSS version 21, Chicago, IL). Mean and median
values of variables were calculated and presented accordingly.
Basic analyses on predictors of ESD technical success and
complications will be performed. Statistical significance was
assumed at a 𝑝 value of <0.05.
3. Results
3.1. Endoscopists. A total of 7 endoscopists from the 5 cen-
ters were involved in this study: Thailand 𝑛 = 3, Singapore
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Figure 1: Endoscopic images of various lesions excised by ESD in this series.
𝑛 = 2, and Malaysia 𝑛 = 2. The median general endoscopy
experience was 17 (range 5–22) years and all endoscopists had
prior EMR experience before embarking on ESD (median 11
years, range 3–15 years). All 7 endoscopists had undergone
animal model training for ESD and 3 of them were trained in
Japan. A median of 25 ESD cases (min 15, max 40) had been
observed prior to commencing ESD individually in patients.
3.2. Case Description. A total of 35 patients had undergone
ESD between 2009 and 2015. 18 (51.4%) cases were female
and the median age was 71 (range 21–85) years. Details of the
lesions are summarized in Table 1. The majority of lesions
identified were in the lower stomach (54.3%). There were a
range of lesions morphologically, with Type 0-IIa being the
commonest; examples of some of these lesions are shown in
Figure 1. ESDwas performed for 6 submucosal lesions, as they
were suspected neuroendocrine tumors (NET). The median
size of lesions was 20mm (IQR 15–25mm), with a range
from 5mm to 60mm. Based on histological evaluation of the
resected specimens (Table 1), the lesions were subsequently
categorized as neoplastic (mucosal dysplasia, neoplasia, or
NET) 𝑛 = 27 (77.1%) and benignmucosal/benign submucosal
lesions 𝑛 = 8 (22.9%).
3.3. ESD Feasibility. 23 (65.7%) cases were performed under
general anaesthesia, 9 (25.7%) cases with Propofol sedation,
and 3 (8.6%) cases with Midazolam sedation alone. The
median duration of ESD procedures was 105 IQR (65–184)
minutes, with a range from 15 to 480 minutes. Figure 2
illustrates the linear relationship between lesion size and the
median duration of ESD procedures.
En-bloc resection was successful in 32/35 lesions (91.4%)
and the remaining 3 lesions were resected in a piecemeal
manner. From en-bloc resected specimens, histologically,
30/35 (85.7%) specimens showed complete resection (R0)
and 2/35 (5.7%) samples had R1 resection (see Table 2).
Six patients had histology suggesting incomplete margin
clearance (duodenal NET 𝑛 = 1, gastric NET 𝑛 = 1, and
gastric adenocarcinoma 𝑛 = 4) and were referred for surgical
resection.
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Table 1: Clinical characteristics of ESD lesions (𝑛 = 35).
Location
Esophagus 3 (8.6%)
Upper stomach 4 (11.4%)
Mid stomach 8 (22.9%)
Lower stomach 19 (54.3%)
Duodenum 1 (2.9%)
Morphology
0-I 4 (11.4%)
0-Is 1 (2.9%)
0-IIa 12 (34.3%)
0-IIc 4 (11.4%)
0-IIa + 0-IIc 8 (22.9%)
Submucosal 6 (17.1%)
Size Median 20 (range 5–60) mm
Histology
Adenocarcinoma 17 (45.8%)
Severe dysplasia 6 (17.1%)
Intestinal metaplasia 1 (2.9%)
Neuroendocrine tumor 3 (8.6%)
Leiomyoma 3 (8.6%)
Ectopic pancreatic tissue 2 (5.7%)
Hyperplastic 1 (2.9%)
Lipoma 2 (5.7%)
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Figure 2: Duration of ESDprocedure in relation to the size of lesion.
3.4. ESD Safety. Significant profuse bleeding was reported
in only 1 (2.9%) case, but this was successfully treated with
hemoclips. All minor bleeding during ESD was managed
immediately with either hemostatic forceps or hemoclips. No
patient required a blood transfusion during or 24 hours after
procedure. There were no perforations and no immediate
mortality resulting from ESD. No complications relating to
sedation/anaesthesia, such as hypoxia or aspiration, were
observed in this series.
3.5. Follow-Up. All patients were followed-up for a median
duration of 24 weeks (range 4–224 weeks). Recurrence was
detected in 2/35 (5.7%) cases—1 with adenocarcinoma (en
bloc, R1) and the other with a gastric NET (en bloc, R0).
EMRwas performed for the adenocarcinoma recurrencewith
complete marginal clearance. The gastric NET recurrence is
Table 2: Outcomes of ESD (𝑛 = 35 cases).
Median duration (minutes) 105 (15–480)
Complete resection
En bloc resection 32 (91.4%)
R0 resection (includes en bloc
and piecemeal specimens) 29 (82.9%)
En bloc with R0 resection 27 (77.1%)
Complications
Delayed bleeding 1 (2.9%)
Perforations 0
Recurrence
Recurrence 2 (9.8%)
beingmonitoredwithout immediate plans for resection as the
original histology was a low-grade NET.
3.6. Predictors of ESD Outcomes. Due to the low number
of complications and high number of en-bloc resections,
predictors of these outcomes could not be analyzed in this
study. “Procedure duration” was therefore evaluated as a
proxy of ESD outcomes in this study. The median duration
of ESD was 105 minutes and procedure duration beyond this
was defined as a poorer outcome. Factors which may have
influenced procedure duration were explored by univariate
analysis (Table 3). Factors related to training (duration
of EMR experience, number of ESD cases observed, and
prior experience in Japan) did not influence ESD procedure
duration.Themain predictor for a prolonged ESD procedure
was the size of the lesion (25mm versus 15mm, 𝑝 = 0.02).
4. Discussion
Most publications of ESD case series have been derived from
high volume centers in Japan and Korea [17, 18], but reports
from Western countries and smaller Asian nations are grad-
ually emerging. A recent nationwide survey from 14 centers
in France performing ESD in the UGIT reported a mean
procedure duration of 108.2±62 (range of 37 to 330)minutes,
en-bloc resection, and R0 rate 91.7% and 71.2%, respectively
[19]. In Taiwan, a multicenter case series reported a median
procedure duration of gastric ESD of 92.4 minutes for lesions
of a median size of 18mm, with an en-bloc resection rate
of 91% [8]. In this multicenter, multinational case series
from South East Asia, the median procedure duration of 105
minutes for lesions with a median size of 20mm, with an
RO resection rate of 85.7%, compares favourably to these
published reports fromnon-Japanese/Korean centers. Table 4
is a brief summary comparing ESD experiences from low
volume centers from different regions.
There were no major complications from this case series,
probably due to the smaller number of cases. Perforations
complicating ESD have been reported to range from 1.2% to
5.2% and delayed bleeding from 0% to 15.6% [20]. However,
the <100% en-bloc resection rate, with tumor recurrence,
was probable indicator of operator inexperience. In our
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Table 3: Predictive factors for a prolonged ESD duration.
Prolonged ESD duration (>105mins)
𝑝
Yes (𝑛 = 17) No (𝑛 = 18)
Cases done by endoscopists with training in Japan (total 𝑛 = 16) 9 (56.3%) 7 (43.7%) 0.4#
Endoscopy training (median years) 18 17 0.62∗
ESD cases observed (median number) 30 40 0.06∗
Previous EMR experience (median years) 11 9.5 0.40∗
Location of lesion
Lower stomach 4 (21.1%) 15 (78.9%)
0.29#
Non-lower stomach 6 (37.5%) 10 (62.5%)
Lesion morphology
Flat/depressed (0-IIc) 8 (42.1%) 11 (58.9%)
0.51#
Elevated (0-IIa) 9 (56.3%) 7 (44.7%)
Size of lesion (median mm) 25 15 0.02∗
∗Mann–Whitney U test.
#Chi-square test.
Table 4: Summary of ESD in upper GI tract outcomes from low-volume centres in the world.
Taiwan [8] Italy [23] Portugal [27] France [19] South East Asia (thisstudy)
Year 2004–2007 2005–2011 2005–2008 2010–2013 2009–2015
Centers 8 2 1 14 5
Study method Retrospective Retrospective Retrospective Prospective Retrospective
Number of ESD cases 70 20 19 177 (upper GI only) 35
Size (mm) Mean 32.6 ± 13.9 Median 29 (15–60) Median 25 (15–30) Mean 39 ± 23 Median 20 (5–60)
Procedure time
(minutes) Median 92.4 (25–210) Medial 119.1 (40–240) Median 90 (40–300) Mean 108.2 ± 62 Median 105 (15–480)
Knife used IT knifeNeedle knife
IT knife
Hook knife
IT knife
Hook knife
Dual knife
Flush knife
IT knife
Hybrid knife
Outcomes
En bloc resection, 𝑛
(%) 64/70 (91.4%) — 15/19 (79%) 292/319 (91.5%) 32/35 (91.4%)
R0 en bloc
resection, 𝑛 (%) NA 18/20 (90%) 13/19 (68%) 277/319 (71.2%) 27/32 (77.1%)
Complications
Bleeding, 𝑛 (%) 4/70 (5.7%) 0 1/19 (5.3%) 15 (4.7%) 1 (2.9%)
Perforation, 𝑛 (%) 3/70 (4.3%) 3/20 (15%) 0 26 (8.1%) 0
Recurrence
Esophagus, 𝑛 (%) — NA — 4/60 (6.7%) 0
Stomach, 𝑛 (%) 2/70 2.8% NA 0 5/63 (6.1%) 2/35 (9.8%)
ESD: Endoscopic submucosal dissection; R0: complete resection with no margin involvement; NA: not available; and IT: insulated tip.
series, 19 (54.3%) lesions located in the lower portion of
the stomach had a successful en-bloc resection, except for
a single lesion. Location of a lesion in the upper part of
stomach, previous scars, and an undifferentiated pathologic
type have been identified as risk factors for not achieving
an en-bloc resection [18]. Local recurrence occurred in 2
(5.7%) cases in this series. A previous meta-analysis by Lian
et al. has suggested that tumor recurrence is much lower
for ESD when compared to EMR [17]. However rates of
tumor recurrence post ESD have been shown to vary from
2% to 35% [21]. Piecemeal resection and resection margin
involvement by tumor are two main reasons for recurrence
after ESD. En-bloc resection is the single most important
factor for a curative ESD without recurrence, which can give
a disease-specific 5-year overall survival of 97.1%–100% [22].
Six patients who had incomplete histological clearance had
subsequent surgery. However, no residual tumor cells were
present in surgically resected specimens. It is likely that the
ESD had actually been successful, but histology had been
inaccurate or cautery effect at the resection margin may have
ablated tumor outside the resected specimen.
A prolonged duration of ESD can lead to unwanted
complications resulting from sedative or anaesthetic
medications. Furthermore, many of the patients requiring an
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ESD procedure are elderly (median age 71 years in this case
series), with the potential of cardiorespiratory complications
with sedation/anaesthesia. Hence, a prolonged duration of
procedure has been accepted as an undesirable outcome of
ESD [18]. In a large retrospective series of 1000 ESD cases
from Korea, Chung et al. defined >60 minutes as a prolonged
ESD duration and identified large size of lesion, upper
stomach location of tumor, presence of scar, recurrent lesion,
and flat macroscopic morphology as predictors [18]. Of these
factors, large size of lesion (OR 4.5) and recurrent lesion
(OR 3.0) were the most predictive of a prolonged duration of
procedure. In our small series, we similarly identified that a
larger size of lesion, but no other characteristics, influenced
the duration of ESD procedure. It is likely that the small
sample size in this series prohibited an accurate assessment
of the other factors other than size, that is, Type 2 statistical
error.
ESD was initially developed for en-bloc resection of
mucosal tumors. Due to its technical success and an improve-
ment in accessories which can be used for closure of trans-
mural perforations, ESD has expanded to include resection
of various submucosal tumors in the stomach. An initial
study by Li et al. on 29 neuroendocrine tumors showed
that 28 lesions (96.6%) in the upper GI tract could be
completely resected, with only 1 case of delayed bleeding, 0
perforations, and 1 recurrence [9]. Several other case series
have recently reported successful ESD for various gastric
submucosal tumors such as ectopic pancreas, ectopic spleen,
leiomyoma, and gastrointestinal stromal tumor (GIST) [23,
24]. In another case series from France, the authors reported
successful resection of 33 submucosal lesions in the stomach
for lesions <20mm, with the majority of lesions being
resected by ESD [25]. In this study, 6 lesions dissected were
submucosal in origin. All lesions were resected safely without
any complications, indicating that ESD for these deeper
lesions was feasible even in low volume centers.
Data from this case series may have been limited by
the self-reporting method of individual endoscopists. Nev-
ertheless, the modest records of procedure duration are
indicative of ESD being performed in a low volume setting.
The recent large series of ESD in multiple centers in France
[19] and a prior study in Nagano [26] suggest that center
volume may not necessarily be the sole factor affecting
outcomes in ESD. Unlike young Japanese endoscopists who
embark on ESD, endoscopists here develop a significant
amount of experience in therapeutic endoscopy prior to
performing ESD. In particular, standard EMR for lesions
in the GI tract share many technical aspects with ESD,
namely, chromoendoscopy, submucosal elevation prior to
resection, and use of electrocautery devices and that of clips
for closure of mucosal defects after resection. We concur
with a recent review article which suggested that ESD can be
taken up by non-Japanese endoscopists who were proficient
in conventional EMR and had undergone sufficient training
in animal models [10]. Although EGC may not be common
in this region, the expanding role of ESD as a minimally
invasive therapeutic modality for gastric submucosal tumors
and other such lesions indicates that there is still a need for
developing this skill among endoscopists in this region.
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